LF
Luke Fletcher
Physician · The US Oncology Network
Credentials: · · · · · ·
History
2021–Present
- 2015–2018
Internal Medicine
- 2011–2015
Doctor of Medicine
Research
Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening
Cancer Research · 2013 · 132 citations
MET receptor sequence variants R970C and T992I lack transforming capacity
Cancer Research · 2010 · 65 citations
IDH Inhibitors in AML-Promise and Pitfalls
Review · Current Hematologic Malignancy Reports · 2021 · 51 citations
3 papers
- CB
3 papers
- ML
3 papers
2 papers
- ET
2 papers
2 papers
2 papers
2 papers
Clinical trials
- 2022–2027
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Site PI · Recruiting · Phase 1, Phase 2
Sumitomo Pharma America, Inc.